Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 241 of 241 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/04/19
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 08/31/15
End: 07/31/18
Due: 07/31/19
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 03/31/12
Due: 03/31/13
Biomechanical Characteristics of Lower Extremity During Pinnacle Trainer With Different Pedal Angles
Phase: N/A
Priority: Normal
Start: 07/01/22
End: 01/15/23
Due: 01/15/24
Phase: N/A
Priority: Normal
Start: 08/01/19
End: 07/31/22
Due: 07/31/23
Neoadjuvant Tislelizumab, Gemcitabine, Cisplatin and S-1 for Resectable High-risk Cholangiocarcinoma
Phase: N/A
Priority: Normal
Start: 07/01/25
End: 07/01/29
Due: 07/01/30
Phase: N/A
Priority: Normal
Start: 08/19/20
End: 12/31/22
Due: 12/31/23
Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer
Phase: N/A
Priority: Normal
Start: 09/30/12
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 05/31/08
End: 10/31/10
Due: 10/31/11
Phase: N/A
Priority: Normal
Start: 01/31/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 03/07/16
End: 10/12/17
Due: 10/12/18
Phase: N/A
Priority: Normal
Start: 12/11/18
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 04/20/24
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 06/28/23
End: 07/31/24
Due: 07/31/25
Phase: N/A
Priority: Normal
Start: 07/05/23
End: 01/05/26
Due: 01/05/27
Phase: N/A
Priority: Normal
Start: 07/13/23
End: 12/31/25
Due: 12/31/26